APOBEC3B and breast cancer: APOBEC3B (A3B) has been implicated in driving genetic heterogeneity in cancers by inducing C > T transitions and C > G transversions at 5’-TCW motifs (W = A or T) [11, 12], a mutation pattern observed in more than 50% of primary breast cancers [11, 12].